Product Code: GVR-4-68040-082-3
Plant-based API Market Summary
The global plant-based API market size was estimated at USD 31.78 billion in 2024 and is projected to reach USD 53.21 billion by 2033, growing at a CAGR of 5.9% from 2025 to 2033. The market is progressing steadily as pharmaceutical companies shift toward natural-origin ingredients supported by strong therapeutic relevance.
Demand is increasing as patients and clinicians show greater confidence in botanical actives that deliver cleaner impurity profiles and favorable safety outcomes. For instance, in September 2025, Current Issues in Molecular Biology published a review describing how metabolic engineering raised terpenoid production, including paclitaxel, by 25-fold and enhanced artemisinin yield by 38% in engineered systems. Multi-omics approaches, including genomics, transcriptomics, and metabolomics, revealed key biosynthetic genes and regulatory networks. Meanwhile, CRISPR tools, enzyme engineering, and subcellular targeting addressed the low natural yields, which often fall below 0.05% dry weight.
The review highlighted challenges such as metabolic flux balancing, cytotoxicity, and scale-up costs, proposing a roadmap to translate lab-scale terpenoid production into industrial manufacturing. This growing interest is encouraging manufacturers to upgrade extraction and purification systems that ensure uniform potency and regulatory compliance across production batches. Drug developers are strengthening pipelines that feature phyto-derived compounds for chronic and lifestyle-driven conditions, which helps establish consistent market momentum. The industry is further supported by scalable cultivation networks that secure dependable raw material availability, allowing producers to maintain continuous output and deliver a stable supply across global markets.
Global Plant-based API Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global plant-based API market report based on molecule type, end use, and region:
- Molecule Type Outlook (Revenue, USD Million, 2021 - 2033)
- Alkaloids
- Anthocyanin
- Flavonoids
- Phenolic Acids
- Terpenoids
- Lignin and Stilbenes
- Others
- End UseOutlook (Revenue, USD Million, 2021 - 2033)
- Pharmaceuticals
- Nutraceuticals
- Herbal Based Industries
- Others
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Molecule Type
- 1.2.2. End Use
- 1.3. Estimates and Forecast Timeline
- 1.4. Research Methodology
- 1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
- 1.6. Information Analysis
- 1.6.1. Data Analysis Models
- 1.7. Market Formulation & Data Visualization
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.9. List of Secondary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Plant-based API Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
- 3.3.1.1. Supplier Power
- 3.3.1.2. Buyer Power
- 3.3.1.3. Substitution Threat
- 3.3.1.4. Threat of New Entrants
- 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis
- 3.3.3. Pipeline Analysis
- 3.3.4. Patent Expiry Analysis
- 3.3.5. Pricing Analysis
Chapter 4. Plant-based API Market: Molecule Type Business Analysis
- 4.1. Molecule Type Market Share, 2024 & 2033
- 4.2. Molecule Type Segment Dashboard
- 4.3. Market Size & Forecasts and Trend Analysis, by Molecule Type, 2021 to 2033 (USD Million)
- 4.4. Alkaloids
- 4.4.1. Alkaloids Market, 2021 - 2033 (USD Million)
- 4.5. Anthocyanin
- 4.5.1. Anthocyanin Market, 2021 - 2033 (USD Million)
- 4.6. Flavonoids
- 4.6.1. Flavonoids Market, 2021 - 2033 (USD Million)
- 4.7. Phenolic Acids
- 4.7.1. Phenolic Acids Market, 2021 - 2033 (USD Million)
- 4.8. Terpenoids
- 4.8.1. Terpenoids Market, 2021 - 2033 (USD Million)
- 4.9. Lignin and Stilbenes
- 4.9.1. Lignin and Stilbenes Market, 2021 - 2033 (USD Million)
- 4.10. Others
- 4.10.1. Others Market, 2021 - 2033 (USD Million)
Chapter 5. Plant-based API Market: End Use Business Analysis
- 5.1. End Use Market Share, 2024 & 2033
- 5.2. End Use Segment Dashboard
- 5.3. Market Size & Forecasts and Trend Analysis, by end use, 2021 to 2033 (USD Million)
- 5.4. Pharmaceuticals
- 5.4.1. Pharmaceuticals Market, 2021 - 2033 (USD Million)
- 5.5. Nutraceuticals
- 5.5.1. Nutraceuticals Market, 2021 - 2033 (USD Million)
- 5.6. Herbal Based Industries
- 5.6.1. Herbal Based Industries Market, 2021 - 2033 (USD Million)
- 5.7. Others
- 5.7.1. Others Market, 2021 - 2033 (USD Million)
Chapter 6. Plant-based API Market: Regional Estimates & Trend Analysis
- 6.1. Regional Market Share Analysis, 2024 & 2033
- 6.2. Regional Market Dashboard
- 6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
- 6.4. North America
- 6.4.1. North America Plant-based API Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
- 6.4.2. U.S.
- 6.4.2.1. Key Country Dynamics
- 6.4.2.2. Target Disease Prevalence
- 6.4.2.3. Regulatory Framework
- 6.4.2.4. Reimbursement Framework
- 6.4.2.5. U.S. Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.3. Canada
- 6.4.3.1. Key Country Dynamics
- 6.4.3.2. Target Disease Prevalence
- 6.4.3.3. Regulatory Framework
- 6.4.3.4. Reimbursement Framework
- 6.4.3.5. Canada Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.4. Mexico
- 6.4.4.1. Key Country Dynamics
- 6.4.4.2. Target Disease Prevalence
- 6.4.4.3. Regulatory Framework
- 6.4.4.4. Reimbursement Framework
- 6.4.4.5. Mexico Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5. Europe
- 6.5.1. Europe Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.2. UK
- 6.5.2.1. Key Country Dynamics
- 6.5.2.2. Target Disease Prevalence
- 6.5.2.3. Regulatory Framework
- 6.5.2.4. Reimbursement Framework
- 6.5.2.5. UK Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.3. Germany
- 6.5.3.1. Key Country Dynamics
- 6.5.3.2. Target Disease Prevalence
- 6.5.3.3. Regulatory Framework
- 6.5.3.4. Reimbursement Framework
- 6.5.3.5. Germany Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.4. France
- 6.5.4.1. Key Country Dynamics
- 6.5.4.2. Target Disease Prevalence
- 6.5.4.3. Regulatory Framework
- 6.5.4.4. Reimbursement Framework
- 6.5.4.5. France Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.5. Italy
- 6.5.5.1. Key Country Dynamics
- 6.5.5.2. Target Disease Prevalence
- 6.5.5.3. Regulatory Framework
- 6.5.5.4. Reimbursement Framework
- 6.5.5.5. Italy Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.6. Spain
- 6.5.6.1. Key Country Dynamics
- 6.5.6.2. Target Disease Prevalence
- 6.5.6.3. Regulatory Framework
- 6.5.6.4. Reimbursement Framework
- 6.5.6.5. Spain Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.7. Denmark
- 6.5.7.1. Key Country Dynamics
- 6.5.7.2. Target Disease Prevalence
- 6.5.7.3. Regulatory Framework
- 6.5.7.4. Reimbursement Framework
- 6.5.7.5. Denmark Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.8. Sweden
- 6.5.8.1. Key Country Dynamics
- 6.5.8.2. Target Disease Prevalence
- 6.5.8.3. Regulatory Framework
- 6.5.8.4. Reimbursement Framework
- 6.5.8.5. Sweden Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.9. Norway
- 6.5.9.1. Key Country Dynamics
- 6.5.9.2. Target Disease Prevalence
- 6.5.9.3. Regulatory Framework
- 6.5.9.4. Reimbursement Framework
- 6.5.9.5. Norway Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6. Asia Pacific
- 6.6.1. Asia Pacific Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6.2. Japan
- 6.6.2.1. Key Country Dynamics
- 6.6.2.2. Target Disease Prevalence
- 6.6.2.3. Regulatory Framework
- 6.6.2.4. Reimbursement Framework
- 6.6.2.5. Japan Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6.3. China
- 6.6.3.1. Key Country Dynamics
- 6.6.3.2. Target Disease Prevalence
- 6.6.3.3. Regulatory Framework
- 6.6.3.4. Reimbursement Framework
- 6.6.3.5. China Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6.4. India
- 6.6.4.1. Key Country Dynamics
- 6.6.4.2. Target Disease Prevalence
- 6.6.4.3. Regulatory Framework
- 6.6.4.4. Reimbursement Framework
- 6.6.4.5. India Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6.5. Australia
- 6.6.5.1. Key Country Dynamics
- 6.6.5.2. Target Disease Prevalence
- 6.6.5.3. Regulatory Framework
- 6.6.5.4. Reimbursement Framework
- 6.6.5.5. Australia Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6.6. South Korea
- 6.6.6.1. Key Country Dynamics
- 6.6.6.2. Target Disease Prevalence
- 6.6.6.3. Regulatory Framework
- 6.6.6.4. Reimbursement Framework
- 6.6.6.5. South Korea Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6.7. Thailand
- 6.6.7.1. Key Country Dynamics
- 6.6.7.2. Target Disease Prevalence
- 6.6.7.3. Regulatory Framework
- 6.6.7.4. Reimbursement Framework
- 6.6.7.5. Thailand Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.7. Latin America
- 6.7.1. Latin America Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.7.2. Brazil
- 6.7.2.1. Key Country Dynamics
- 6.7.2.2. Target Disease Prevalence
- 6.7.2.3. Regulatory Framework
- 6.7.2.4. Reimbursement Framework
- 6.7.2.5. Brazil Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.7.3. Argentina
- 6.7.3.1. Key Country Dynamics
- 6.7.3.2. Target Disease Prevalence
- 6.7.3.3. Regulatory Framework
- 6.7.3.4. Reimbursement Framework
- 6.7.3.5. Argentina Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.8. Middle East and Africa
- 6.8.1. Middle East and Africa Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.8.2. South Africa
- 6.8.2.1. Key Country Dynamics
- 6.8.2.2. Target Disease Prevalence
- 6.8.2.3. Regulatory Framework
- 6.8.2.4. Reimbursement Framework
- 6.8.2.5. South Africa Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.8.3. Saudi Arabia
- 6.8.3.1. Key Country Dynamics
- 6.8.3.2. Target Disease Prevalence
- 6.8.3.3. Regulatory Framework
- 6.8.3.4. Reimbursement Framework
- 6.8.3.5. Saudi Arabia Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.8.4. UAE
- 6.8.4.1. Key Country Dynamics
- 6.8.4.2. Target Disease Prevalence
- 6.8.4.3. Regulatory Framework
- 6.8.4.4. Reimbursement Framework
- 6.8.4.5. UAE Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.8.5. Kuwait
- 6.8.5.1. Key Country Dynamics
- 6.8.5.2. Target Disease Prevalence
- 6.8.5.3. Regulatory Framework
- 6.8.5.4. Reimbursement Framework
- 6.8.5.5. Kuwait Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Participant Overview
- 7.2. Company Market Position Analysis
- 7.3. Company Categorization
- 7.4. Strategy Mapping
- 7.5. Company Profiles/Listing
- 7.5.1. Roquette Freres
- 7.5.1.1. Overview
- 7.5.1.2. Financial Performance
- 7.5.1.3. Product Benchmarking
- 7.5.1.4. Strategic Initiatives
- 7.5.2. Arboris
- 7.5.2.1. Overview
- 7.5.2.2. Financial Performance
- 7.5.2.3. Product Benchmarking
- 7.5.2.4. Strategic Initiatives
- 7.5.3. Centroflora
- 7.5.3.1. Overview
- 7.5.3.2. Financial Performance
- 7.5.3.3. Product Benchmarking
- 7.5.3.4. Strategic Initiatives
- 7.5.4. BASF SE
- 7.5.4.1. Overview
- 7.5.4.2. Financial Performance
- 7.5.4.3. Product Benchmarking
- 7.5.4.4. Strategic Initiatives
- 7.5.5. Kothari Phytochemicals & Industries Ltd.
- 7.5.5.1. Overview
- 7.5.5.2. Financial Performance
- 7.5.5.3. Product Benchmarking
- 7.5.5.4. Strategic Initiatives
- 7.5.6. Evonik Industries AG
- 7.5.6.1. Overview
- 7.5.6.2. Financial Performance
- 7.5.6.3. Product Benchmarking
- 7.5.6.4. Strategic Initiatives
- 7.5.7. Brains (Brains Bioceutical)
- 7.5.7.1. Overview
- 7.5.7.2. Financial Performance
- 7.5.7.3. Product Benchmarking
- 7.5.7.4. Strategic Initiatives
- 7.5.8. Indo Phytochem Pharmaceuticals.
- 7.5.8.1. Overview
- 7.5.8.2. Financial Performance
- 7.5.8.3. Product Benchmarking
- 7.5.8.4. Strategic Initiatives
- 7.5.9. HimPharm.com.
- 7.5.9.1. Overview
- 7.5.9.2. Financial Performance
- 7.5.9.3. Product Benchmarking
- 7.5.9.4. Strategic Initiatives
- 7.5.10. Cargill, Incorporated
- 7.5.10.1. Overview
- 7.5.10.2. Financial Performance
- 7.5.10.3. Product Benchmarking
- 7.5.10.4. Strategic Initiatives